COMMUNIQUÉS West-GlobeNewswire

CORRECTION : Hydropothecary annonce le devancement de l'échéance de bons de souscription
25/05/2018
GATINEAU, Québec, 25 mai 2018 (GLOBE NEWSWIRE) -- Ce document corrige et remplace le communiqué diffusé le 24 mai 2018 à 17H00 HAE. L'erreur se trouve dans le troisième paragraphe. Le prix d'exercice est 3,00 $ et non [...]
Microbot Medical Closes Acquisition of Novel Technology from CardioSert Ltd.
25/05/2018
HINGHAM, Mass., May 25, 2018 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (NASDAQ CM:MBOT), a medical device company specializing in the design and development of transformational micro-robotic medical technologies, today [...]
Oncolytics Biotech® Announces Research Collaboration with the Keck School of Medicine of USC Combining REOLYSIN® with Keytruda®, Velcade® and Dexamethasone
25/05/2018
CALGARY, Alberta and SAN DIEGO, May 25, 2018 (GLOBE NEWSWIRE) -- Oncolytics Biotech ® Inc. (TSX: ONC ) (OTCQX:ONCYF), currently developing REOLYSIN ® (pelareorep), an intravenously delivered immuno-oncolytic virus [...]
Midatech commences US clinical study of its investigational treatment for fatal childhood brain cancer
25/05/2018
25 May 2018 Midatech Pharma PLC (“Midatech”, “Company” or “Group”) Midatech commences US clinical study of its investigational treatment for fatal childhood brain cancer Midatech Pharma (AIM: MTPH, Nasdaq: MTP), the [...]
Protalix BioTherapeutics Announces Poster Presentation on Baseline Characteristics for Fabry Disease Patients Screened in the Phase III BALANCE Study of Pegunigalsidase Alfa at the 55th ERA-EDTA Congress
25/05/2018
Remaining Effective Enzyme in Blood Samples was more than Double for Pegunigalsidase Alfa (PRX-102) Compared to Fabrazyme® as a Result of Higher Inhibition of Neutralizing Antibodies Measured in Fabrazyme CARMIEL, [...]
Avivagen to Pursue Regulatory Approval in Mexico
25/05/2018
OTTAWA, May 25, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV)(“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and [...]
Keryx Biopharmaceuticals Announces Data from an Investigator Sponsored Trial of Ferric Citrate in Patients with Advanced Chronic Kidney Disease in a Late-Breaking Presentation at the 55th Annual ERA/EDTA Today in Copenhagen
25/05/2018
Conference Call Today at 8:30 a.m. EST COPENHAGEN, Denmark, May 25, 2018 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX ), a company focused on bringing innovative medicines to people with kidney [...]
CVs of Proposed Members of the Council of JSC Olainfarm
25/05/2018
CVs of Proposed Members of the Council of JSC Olainfarm AINĀRS OZOLS Education: 2005 – 2006 Stockholm School of Economics, Riga. Executive MBA 1997 – 1999 Latvian Banking Academy. The Latvian banking Certificate [...]
MyoGen : Les leaders d’une révolution anabolique
25/05/2018
GUJARAT, Inde, 25 mai 2018 (GLOBE NEWSWIRE) -- Myogen vous fera repenser les limites du corps humain Être un athlète signifie participer à une quête sans fin d’autoamélioration. Une obsession à la recherche d’un [...]
Bardoxolone Methyl Improved Kidney Function in Patients With Autosomal Dominant Polycystic Kidney Disease and IgA Nephropathy in the Ongoing Phase 2 Phoenix Study
25/05/2018
Interim Data Demonstrate Significant Improvement in Kidney Function in Both Diseases Conference Call With Management Scheduled Today, May 25, 2018 at 8:00am ET IRVING, Texas, May 25, 2018 (GLOBE NEWSWIRE) -- Reata [...]
NeuroSearch A/S: Publication of offer document
25/05/2018
Company Announcement 25 May 2018 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH [...]
Vistin Pharma ASA : Last day of the subscription period in the subsequent repair issue
25/05/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR [...]
ThromboGenics Enrolls First Patient in Phase 1 Clinical Study Evaluating THR-149, a plasma kallikrein inhibitor, for treatment of Diabetic Macular Edema (DME)
25/05/2018
Press release Leuven, Belgium, 25 May 2018 - ThromboGenics NV (Euronext Brussels: THR), a biotechnology company developing novel medicines for diabetic eye disease, announces that it has successfully enrolled the first [...]
Extendicare Announces Voting Results from the 2018 Annual and Special Meeting of Shareholders and Board Change
25/05/2018
MARKHAM, Ontario, May 24, 2018 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE ) today announced the results of matters voted on at its annual and special shareholders’ meeting held on [...]
Burcon Announces Intention to File Form 25
24/05/2018
VANCOUVER, British Columbia, May 24, 2018 (GLOBE NEWSWIRE) -- Burcon NutraScience Corporation (TSX: BU ) (NASDAQ: BUR ) (“Burcon” or the “Company”), a leader in natural product extraction, purification and isolation [...]
Hydropothecary Announces Acceleration of Warrant Expiry Date
24/05/2018
GATINEAU, Quebec, May 24, 2018 (GLOBE NEWSWIRE) -- The Hydropothecary Corporation (“THCX” or the “Company”) (TSX-V: THCX ) announced today that it has elected to exercise its right under the warrant indenture (the “ [...]
Hydropothecary annonce le devancement de l'échéance de bons de souscription
24/05/2018
GATINEAU, Québec, 24 mai 2018 (GLOBE NEWSWIRE) -- La société Hydropothecary (" THCX " ou la " Société ") (TSX CROISSANCE:THCX) a annoncé aujourd'hui qu'elle a choisi d'exercer son droit en vertu de l'acte de fiducie (l [...]
Amarin Announces Patent Litigation Settlement Agreement with Teva
24/05/2018
BEDMINSTER, N.J. and DUBLIN, Ireland, May 24, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN ), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve [...]
Retrophin to Present at Upcoming Investor Conferences
24/05/2018
SAN DIEGO, May 24, 2018 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX ) today announced that the Company’s management team will present at the following upcoming investor conferences in June: Jefferies 2018 Global [...]

Pages